Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Proto-oncogene c-Met (MET) |
Target Info
|
Inhibitor |
[2] |
| References |
Top |
| REF 1 |
AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications. Mol Cancer. 2019 Nov 4;18(1):153.
|
| REF 2 |
NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutants. Invest New Drugs. 2014 Jun;32(3):389-99.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
